(Q34400269)

1 August 2017

1 reference

title

The renin-angiotensin system and vascular hypertrophy (English)

1 reference

1 August 2017

Rosendorff C

1

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 October 1996

1 reference

Journal of the American College of Cardiology

1 August 2017

published in

1 reference

1 August 2017

volume

28

1 reference

1 August 2017

issue

4

1 reference

1 August 2017

page(s)

803-812

1 reference

Molecular biology of the renin-angiotensin system

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

The renin-angiotensin system: an overview of its intracellular function

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Angiotensin converting enzyme inhibition and vascular hypertrophy in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Molecular biology of hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Vascular renin-angiotensin system and vascular protection.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Molecular biology of the renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Effects of angiotensin and angiotensin blockade on coronary circulation and coronary reserve.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Molecular Biology of the Vascular Renin-Angiotensin System

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Extra-renal transcription of the renin genes in multiple tissues of mice and rats

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

[Autacoids and their role in the pathogenesis of cough induction by angiotension converting enzyme inhibitor]

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Release of a Prostaglandin E-Like Substance from Canine Kidney by Bradykinin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Stimulation of cyclic GMP production in cultured endothelial cells of the pig by bradykinin, adenosine diphosphate, calcium ionophore A23187 and nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Inhibition of the Angiotensin Converting Enzyme by Perindoprilat and Release of Nitric Oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Vascular renin-angiotensin system in two-kidney, one clip hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Changes in gene expression of the renin???angiotensin system in two-kidney, one clip hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Mesenteric resistance and brain microvascular angiotensin-converting enzyme in the spontaneously hypertensive rat

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Characterization of angiotensin converting enzyme in isolated cerebral microvessels from spontaneously hypertensive and normotensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Levels of angiotensin and molecular biology of the tissue renin angiotensin systems

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Different distribution of two types of angiotensin II-generating enzymes in the aortic wall

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Chymase-dependent angiotensin II forming systems in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Feedback regulation of angiotensin converting enzyme activity and mRNA levels by angiotensin II

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Proposed update of angiotensin receptor nomenclature.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Expression of AT2 receptors in the developing rat fetus

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Differential distribution of AT1 and AT2 angiotensin II receptor subtypes in the rat brain during development

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Characterization of AT2 angiotensin II receptors in rat anterior cerebral arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Characterization and development of angiotensin II receptor subtypes (AT1 and AT2) in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Changes in expression of angiotensin receptor subtypes in the rat aorta during development.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Role of angiotensin subtype 2 receptor in neointima formation after vascular injury

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Peptide growth factors markedly decrease the ligand binding of angiotensin II type 2 receptor in rat cultured vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Angiotensin II signal transduction pathways in the cardiovascular system

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Inositol trisphosphate and diacylglycerol: two interacting second messengers

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Protein kinase C in transmembrane signalling

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Angiotensin II-induced mitogenesis of spontaneously hypertensive rat-derived cultured smooth muscle cells is dependent on autocrine production of transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Role of transforming growth factor-beta 1 in the cellular growth response to angiotensin II

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Spontaneously hypertensive rat vascular smooth muscle cells in culture exhibit increased growth and Na+/H+ exchange

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Angiotensin II-induced proliferation of aortic myocytes in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Cellular hypertrophy in mesenteric resistance vessels from renal hypertensive rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Evidence for hyperplasia in mesenteric resistance vessels of spontaneously hypertensive rats using a three-dimensional disector.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Histology of subcutaneous small arteries from patients with essential hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Morphology and function of mesenteric resistance arteries in transgenic rats with low-renin hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Angiotensin II induces expression of the c-fos gene through protein kinase C activation and calcium ion mobilization in cultured vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Angiotensin II induces c-fos expression in smooth muscle via transcriptional control.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Induction of the proto-oncogene c-jun by angiotensin II.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Angiotensin II can regulate gene expression by the AP-1 binding sequence via a protein kinase C-dependent pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Activation of human peripheral monocytes by angiotensin II

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Essential hypertension: renin and aldosterone, heart attack and stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

"Structural factor" in primary and secondary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Angiotensin II: hemodynamic regulator or growth factor?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Effects of chronic inhibition of converting enzyme on mechanical and structural properties of arteries in rat renovascular hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Prevention of hypertension and vascular changes by captopril treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Renin in rats with spontaneous hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Renin-angiotensin system in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Cardiac hypertrophy in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Effects of hydralazine on blood pressure, pressor mechanisms, and cardiac hypertrophy in two-kidney, one-clip hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Central and peripheral indices of sympathetic activity after blood pressure lowering with enalapril (MK-421) or hydralazine in normotensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Prenatal and postnatal hydralazine treatment does not prevent renal vessel wall thickening in SHR despite the absence of hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Influence of blood pressure on development of aortic medial smooth muscle hypertrophy in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin I-converting enzyme inhibitor. Comparison with effects of a beta-blocker.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Impaired systemic arterial compliance in borderline hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Haemodynamic basis of early modifications of the large arteries in borderline hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

An evaluation of large arteries compliance in man

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Systolic hypertension: hemodynamic mechanism and choice of antihypertensive treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Arterial compliance in systolic hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Comparison of oral MK 421 and propranolol in mild to moderate essential hypertension and their effects on arterial and venous vessels of the forearm

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Effects of acute and chronic angiotensin-converting enzyme inhibition on large arteries in human hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

The role of antihypertensive drugs in counteracting adverse influence on large arteries.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Reversion of cardiac hypertrophy and reduced arterial compliance after converting enzyme inhibition in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

The influence of perindopril and the diuretic combination amiloride+hydrochlorothiazide on the vessel wall properties of large arteries in hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

The effect of acute and chronic nicardipine therapy on forearm arterial haemodynamics in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Post-synaptic alpha-blockade and brachial artery compliance in essential hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Comparative haemodynamic effects of ketanserin and ritanserin in the proximal and distal upper limb circulations of hypertensive patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

The efficacy of a transdermal formulation of clonidine in mild to moderate hypertension and its effects on the arterial and venous vasculature of the forearm

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

The renin-angiotensin system and arterial wall behavior.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Haemodynamic effects of metoprolol and pindolol: a comparison in hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

The influence of antihypertensive therapy on the structural arteriolar changes in essential hypertension: different effects of enalapril and hydrochlorothiazide

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Effects of angiotensins on cellular hypertrophy and c-fos expression in cultured arterial smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

EXP3174, a metabolite of losartan (MK954, DuP753) is more potent than losartan in blocking the angiotensin ll-induced responses in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Angiotensin II increases proto-oncogene expression and phosphoinositide turnover in vascular smooth muscle cells via the angiotensin II AT1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Losartan inhibits the angiotensin II-induced stimulation of the phosphoinositide signalling system in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Chronic angiotensin II type 1 receptor antagonism in genetic hypertension: effects on vascular structure and reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Angiotensin II receptor antagonist losartan has persistent effects on blood pressure in the young spontaneously hypertensive rat: lack of relation to vascular structure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

Evidence for direct local effect of angiotensin in vascular hypertrophy. In vivo gene transfer of angiotensin converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900251-3

7 January 2021

10.1016/S0735-1097(96)00251-3

Identifiers

DOI

1 reference

1 August 2017

1 reference